MORTALITY FOR ESSENTIAL HYPERTENSION IN BRAZIL BETWEEN 2015 AND 2019 - AN ANALYSIS OF DATASUS
DOI:
https://doi.org/10.58043/rphrc.15Abstract
Introduction: Essential hypertension (HE) is the main risk factor for cardiovascular diseases in the world and can progress to chronic non- communicable diseases, which reduces the quality and life expectancy of those affected.
Objective: To expose essential hypertension (HE) mortality in Brazil in the period between 2015 and 2019.
Methods: An epidemiological, retrospective, descriptive and analytical study of a historical series was carried out. Data were obtained from the Department of Informatics of SUS (DATASUS). The following parameters were evaluated: absolute number of deaths, mortality rate, age group, race, sex and place of death. The findings were presented in tables and graphs, according to descriptive statistics and using percentage results. This study was not presented for consideration by the Research Ethics Committee, since the information discussed here is freely accessible online, of interest and public consultation.
Results: Deaths registered by HE have decreased in recent years. The average mortality rate for the period was 1.64. The region with the highest mortality rate recorded during the study period was the Northeast, followed by the Southeast, North, Center-West and South. Individuals of the indigenous race and males had higher mortality rates. Mortality progressed with increasing age.
Conclusion: The characterization of mortality from HE in the different regions of Brazil showed a predominance in the Northeast region, in individuals of the indigenous and black races, in males and in the age of 80 years or more. Despite the drop in mortality, there were significant mortality rates, which corroborates the need for more effective measures to control and raise awareness among the population, especially among the most vulnerable groups, regarding the prevention and risks of HE.
Downloads
References
World Health Organization (WHO). Global Atlas on Cardiovascular Disease Prevention and Control. Mendis S, Puska P, Norrving B editors. Geneva: World Health Organization; 2011.
Lima e Costa MFF, Guerra HL, Barreto SM, Guimarães RM. Diagnóstico da situação de saúde da população idosa brasileira: um estudo da mortalidade e das internações hospitalares públicas. Informe Epidemiológico do SUS 2000;9(1):23-41.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-104.
Lawes CMM et al. Global burden of blood-pressure-related disease, 2001. The Lancet . 2008; 371(9623): 1513 – 1518.
Deanfield J, Sattar N, Simpson I, et al., Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease. Heart. 2014; 100(SUPPL. 2): ii1-ii67.
Dantas RCO, Silva JPT, Dantas DCO, et al. Fatores associados às internações por hipertensão arterial. Einstein (São Paulo). 2018;16(3):eAO4283.
Alfradique ME, Bonolo PF, Dourado I, Lima-Costa MF, Macinko J, Mendonça CS, Oliveira VB, Sampaio LFR, Simoni C, Turci MA. Internações por condições sensíveis à atenção primária: a construção da lista brasileira como ferramenta para medir o desempenho do sistema de saúde (Projeto ICSAP – Brasil). Cad. Saúde Pública, Rio de Janeiro, 2009; 25(6): 1337-49.
Mancilha-Carvalho JJ, Carvalho JV, Lima JAC, Silva NAS. Ausência de fatores de risco de doença coronária em índios Yanomami e influência da aculturação na pressão arterial. Arq Bras Cardiol. 1992;59(4):275-83.
Nadruz W, Claggett B, Shah AM, et al. Racial disparities in risks of stroke. N Engl J Med. 2017; 376:2089-2090.
Silva SSBE, Oliveira SFSB, Pierin AMG. The control of hypertension in men and women: a comparative analysis. Rev Esc Enferm USP. 2016;50(1):50-8.
Luz PL, Solimene MC. Peculiaridades da doença arterial coronária na mulher. Rev. Ass. Med. 1999 Mar; 45(1):45-54.
Marafon LP, Cruz IBM, Schwanke CHA, et al. Preditores cardiovasculares da mortalidade em idosos longevos. Cad. Saúde Pública, Rio de Janeiro, 2003; 19(3):799-808.
